Role of SFRP5 in Non-Small Cell Lung Cancer and Its Correlation with SUV of 18F-FDG PET-CT

被引:0
|
作者
Zhang, Na [1 ]
Bai, Tian [1 ]
Jiang, Yunfei [2 ]
Zhu, Kun [3 ]
Yao, Lan [4 ]
Ji, Jia [5 ]
Huang, Qicheng [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Radiog Imaging Ctr, Qiqihar, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Resp Dept, Qiqihar, Peoples R China
[3] Qiqihar Med Univ, Affiliated Hosp 3, Cardiothorac Surg Dept, Qiqihar, Peoples R China
[4] Qiqihar Med Univ, Affiliated Hosp 3, Nucl Med Dept, Qiqihar, Peoples R China
[5] Qiqihar Med Univ, Affiliated Hosp 3, Stomatol Dept, Qiqihar, Peoples R China
关键词
SFRP5; non-small cell lung cancer; 18F-FDG PET-CT; cell proliferation; cell metastasis; WNT; EXPRESSION; MUTATION; MARKERS;
D O I
10.1080/08941939.2024.2381722
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: This study aimed to evaluate the relationship between secreted frizzled-related protein 5 (SFRP5) expression and fluorine 18-fluoro-deoxyglucose (18 F-FDG) uptake imaged with positron emission tomography/tomography (PET/CT) in patients with non-small cell lung cancer (NSCLC). In addition, we sought to elucidate the potential role and mechanism of action of SFRP5 in NSCLC.Materials and methods: The maximum standardized uptake value (SUVmax) of the lesions was calculated. SFRP5 expression was analyzed using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The correlation between SFRP5 expression and SUVmax was evaluated using Pearson's correlation analysis. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), flow cytometry, wound healing, and transwell assays were used to analyze cell viability, apoptosis, migration, and invasion, respectively.Results and conclusion: The results indicated that the SUVmax was higher in patients with NSCLC than that in healthy volunteers. Moreover, SFRP5 expression was lower in tissues from the four types of NSCLC than that in the adjacent normal tissues. SUVmax negatively correlated with SFRP5 expression in the four types of NSCLC. In addition, up-regulation of SFRP5 decreased the viability, migration, and invasion abilities, and increased apoptosis of NSCLC cells. Furthermore, SFRP5 inhibited the Wnt/beta-catenin pathway in NSCLC cells. In conclusion, SFRP5 modulates the biological behaviors of NSCLC through Wnt/beta-catenin pathway.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Prognostic value of 18F-FDG PET/CT quantitative metrics in non-small cell lung cancer
    Fontao de Castro, S.
    Prospero, I.
    Violante, L. S.
    Ferreira, G.
    Teixeiro, J.
    Duarte, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S83 - S84
  • [22] Comparison of 18F-FDG PET/CT and MDCT for Detection Metastases of Non-Small Cell Lung Cancer
    Sobic-Saranovic, D.
    Petrusic, I.
    Artiko, V.
    Kozarevic, N.
    Odalovic, S.
    Grozdic-Milojevic, I.
    Stoiljkovic, M.
    Obradovic, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S485 - S485
  • [23] Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer
    Yu, Hui Ming
    Liu, Yun Fang
    Hou, Ming
    Liu, Jie
    Li, Xiao Nan
    Yu, Jin Ming
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2009, 72 (01) : 104 - 113
  • [24] Role of 18F-FDG PET/CT in preoperative staging of non-small-cell lung cancer
    Nikoletic, K.
    Srbovan, D.
    Mihailovic, J.
    Matovina, E.
    Kozic, D.
    Kolarov, V.
    Prvulovic, N.
    Miucin-Vukadinovic, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S568 - S568
  • [25] Pre-radiotherapy assessment of non-small cell lung cancer with 18F-FLT PET/CT or 18F-FDG PET/CT
    Xu, Xiaoting
    Nie, Liangqin
    Yao, Yimin
    Tu, Yu
    Zhou, Juying
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 9252 - 9260
  • [26] Correlation of SUV on 18F-FDG PET Uptake with Ki-67/MIB-1 index in Non-small Cell Lung Cancer
    Mestre-Fusco, A.
    Simo, M.
    Pijoan, L.
    Baro, T.
    Casado, B.
    Mojal, S.
    Rodriguez, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S294 - S294
  • [27] Automatic segmentation of tumour volume for non-small cell lung cancers with the 18F-FDG PET-CT for treatment by radiotherapy
    Boursot, C.
    Le Borgne, A.
    Barillot, I.
    Venel, Y.
    de Muret, A.
    Baulieu, J-L.
    Prunier-Aesch, C.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (07): : 440 - 449
  • [28] Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
    Schaarschmidt, Benedikt M.
    Grueneisen, Johannes
    Metzenmacher, Martin
    Gomez, Benedikt
    Gauler, Thomas
    Roesel, Christian
    Heusch, Philipp
    Ruhlmann, Verena
    Umutlu, Lale
    Antoch, Gerald
    Buchbender, Christian
    [J]. EUROPEAN RADIOLOGY, 2017, 27 (02) : 681 - 688
  • [29] Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
    Benedikt M. Schaarschmidt
    Johannes Grueneisen
    Martin Metzenmacher
    Benedikt Gomez
    Thomas Gauler
    Christian Roesel
    Philipp Heusch
    Verena Ruhlmann
    Lale Umutlu
    Gerald Antoch
    Christian Buchbender
    [J]. European Radiology, 2017, 27 : 681 - 688
  • [30] Radiomic Analysis of FDG PET-CT in Non-Small Cell Lung Cancer
    Albattat, Khamael
    Smith, Rhodri
    Morley, Nicholas
    Marshall, Christopher
    [J]. QUALITY OF LIFE RESEARCH, 2023, 32 (SUPPL 1) : S16 - S16